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Transition Metal-Free Reduction of Activated Alkenes using a 
Living Microorganism 
Richard C. Brewster, Jack T. Suitor, Adam W. Bennett and Stephen Wallace* 
 
Abstract: Microorganisms can be programmed to perform chemical 
synthesis via metabolic engineering. However, despite an increasing 
interest in the use of de novo metabolic pathways and designer whole-
cells for small molecule synthesis, the inherent synthetic capabilities 
of native microorganisms remain underexplored.  Herein we report the 
use of unmodified E. coli BL21(DE3) cells for the reduction of keto-
acrylic compounds and apply this whole-cell biotransformation to the 
synthesis of aminolevulinic acid from a lignin-derived feedstock. The 
reduction reaction is rapid, chemo- and enantioselective, occurs 
under mild conditions (37 ˚C, aqueous media) and requires no toxic 
transition metals or external reductants. This study demonstrates the 
remarkable promiscuity of central metabolism in bacterial cells and 
how these processes can be leveraged for synthetic chemistry without 
the need for genetic manipulation. 
Synthetic biology is revolutionizing the field of chemical synthesis. 
This approach uses recombinant DNA to enable the synthesis of 
a small molecule target directly from renewable feedstocks via 
fermentation.[1] Despite the elegance of this approach, microbial 
cells are frequently used in forward engineering endeavors as a 
biosynthetic starting-point, where synthetic capabilities are added 
via the introduction of new genetic parts. The background native 
chemical capabilities of these organisms remain underexplored. 
Research into the synthetic potential of native microbial cells 
could reveal new reactivity for use in synthetic chemistry and 
would also yield reactions that are inherently linked to cellular 
metabolism for use in metabolic pathway design. Furthermore, 
these reactions can also be interfaced with transition metal 
catalysis for the renewable synthesis of non-natural chemicals.[2]  
In a seminal example, Balskus et al. used H2(g) generated via 
engineered metabolism in E. coli DD-2 to hydrogenate a range of 
alkene substrates using the biocompatible Royer Pd catalyst.[2d] 
 However, alkene reduction is also an inherent metabolic 
process of many native microorganisms. For example, facultative 
anaerobes use small organic molecules to respire via a reductive 
process. A classic example is the reduction of fumarate by 
fumarate reductase. This flavin-dependent C=C bond reduction 
can be used to support growth and replication under anaerobic 
conditions (Figure 1A). Other native enzymes can also be used to 
reduce C=C bonds. For example, E. coli BL21(DE3) and DH5 
cells have been shown to reduce conjugated nitroalkenes in 
moderate yields and this has been attributed, in part, to the activity 
of the reductase NemA.[3] Furthermore, native Old Yellow 
Enzymes in the yeast Saccharomyces cerevisiae have also been 
used to reduce -substituted, ,-unsaturated carbonyl 
compounds in a stereospecific manner.[4] 
  
Figure 1. Cellular approaches to alkene reduction. A) Native respiratory 
enzymes reduce activated alkenes under anaerobic conditions. B) Metabolic 
H2(g) production can be interfaced with a biocompatible Pd catalyst for the 
reduction of coumaric acids. C) Exploring the native reductive capability of 
unmodified microorganisms for transition metal-free keto-acrylate reduction. 
Inspired by these studies, we set out to investigate the reduction 
of substituted keto-acrylic compounds (KACs) by microbial cells 
(Figure 1C). KACs feature in a range of pharmaceutical and fine 
chemical syntheses and are predominantly reduced in organic 
solvent using transition metals under an atmosphere of H2(g). 
Biocatalytic approaches to KAC reduction have been limited to in 
vitro studies using purified enzymes. In 2014, Pietruszka et al. 
reported the use of the enoate reductase YqjM from Bacillus 
subtilis for the reduction of short-chain KACs in vitro and coupled 
this with an alcohol dehydrogenase (ADHLK) to synthesize chiral 
-butyrolactones.[5] Despite the elegance of this approach, the 
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strict cofactor dependence of YqjM and ADHLK requires the use 
of exogenous NADPH and FMN, which must also be regenerated 
in situ using additional enzymes. The reaction also requires 
constant buffering using a pH-stat. There are currently no 
methods to achieve this reaction using green synthetic methods 
or microbial whole cells. 
We reasoned that the similarity of the KAC motif to fumarate 
suggested that native microbial cells could facilitate this 
transformation without the need for genetic manipulation. This 
hypothesis was inspired by our previous studies in biocompatible 
chemistry where reduction of the unnatural compound diethyl 
maleate was observed during a cyclopropanation reaction and 
attributed to the metabolic activity of E. coli NST74.[2b] 
Furthermore, E. coli possesses a series of YqjM homologues in 
its genome ( ≤ 33% identity, Table S10) and can generate 
reducing equivalents in situ via oxidative glucose metabolism. 
Therefore, we set out to investigate whether keto-acrylate 
reduction could be performed by living E. coli cells and, if so, 
whether this could be used in the synthesis of an industrially-
relevant small molecule. Herein we report the discovery that the 
common laboratory strain of bacteria E. coli BL21(DE3) can 
reduce a range of keto-acrylates without the need for genetic 
modification. This whole-cell reaction is mild, efficient, 
enantioselective and represents an operationally simple and 
green alternative to current transition metal-based methods that 
utilize H2(g).  
We began our studies by investigating whether E. coli could 
reduce butenyl-substituted keto-acrylate esters 1 in cell culture 
(Figure 2A). The butenyl side chain was included to assess the 
chemoselectivity of any observed reduction. The benzyl ester 1-
Bn was included to localize the substrate to the cell membrane, 
and the carboxylic acid 1-H was used as a hydrophilic control. 
Substrates were synthesized in 4 steps from commercially 
available glyoxal dimethyl acetal via a Horner-Wadsworth-
Emmons olefination, acetal hydrolysis, Grignard addition and 
oxidation (see S2.1). The laboratory strain E. coli BL21(DE3) was 
chosen due to its widespread availability in molecular biology labs 
and its well-annotated genome. We were pleased to find that C=C 
reduction occurred for all the compounds tested, as confirmed by 
1H NMR (Figure 2B, C). The methyl and ethyl esters 1-Me and 1-
Et were reduced in 39% and 43% yield, respectively, and were 
isolated alongside significant quantities of hydrolyzed substrate 
and product (Table S1). Hydrolysis was reduced to 8% using the 
bulkier benzyl ester 1-Bn, which increased the product yield to 
69%. However, use of the carboxylic acid substrate 1-H 
eliminated this side-reaction and provided the desired reduced 
product 2-H in quantitative yield (Figure 2C).  
To determine whether the reaction was biocompatible we 
analyzed its effect on E. coli cells (Figure 2D and Table S2). The 
methyl and ethyl esters 1-Me/1-Et were highly toxic and the 
benzyl ester reduced cell viability by 400-fold (Figure 2D, columns 
2-4). The most biocompatible substrate was the carboxylic acid 1-
H, which caused only a 2-fold drop in cell viability after 48 h 
(Figure 2D, column 5). This observation suggested that the 
toxicity of 1-Me/1-Et may be due to the release of MeOH/EtOH 
into the cell. However, when we cultured cells in the presence of 
1-H and an equimolar volume of EtOH, no toxicity was observed. 
Instead, cell viability increased by 3-fold (P<0.001, Figure 2D, 
column 6 and Table S8). The addition of EtOH is known to mimic 
the heat shock response in E. coli and increases the rigidity of the 
cell membrane, an effect that could account for this observation.[6]  
At this point, due to poor product conversions, competing 
hydrolysis and the high toxicity of reactions involving 1-Me and 1-
Et we decided to focus the remainder of this study on the benzyl 
ester and carboxylic acid 1-Bn and 1-H.  
Next, we tested the reaction at higher substrate concentration and 
investigated the rate of product formation during the reaction. 
Increasing the concentration of carboxylic acid 1-H to 5 mM (ca. 
0.8 g/L) decreased the yield of the reaction to 66% and reduced 
cell density by 77% (Figure 3A, columns 2-4). Interestingly, using 
5 mM (ca. 1.2 g/L) of the benzyl ester 1-Bn increased the reaction 
yield to 79% and increased the cell density to 118% of control 
samples containing no substrate (Figure 3A, columns 5-7). 
Figure 2. A) Initial KAC ester and carboxylic acid screen. B) Product 
identification via comparison of culture extracts with a synthetic standard by 1H-
NMR. C) Product yields for various substrate esters and carboxylic acid. D) 
Serial dilution and plate count assays. All substrates were added at 1 mM 
concentration. Reactions were performed in sealed Hungate tubes under an 
atmosphere of air for 48 h. E. coli BL21(DE3) cells transformed with an empty 
pEdinBrick plasmid (pSB1A2 derived, OD600=0.6) were used to ensure the 
presence of a monoculture. All cultures were grown in M9 media containing D-
glucose (4 g/L) and ampicillin (100 mg/L). Product concentrations in crude 
culture extracts were determined by 1H NMR spectroscopy relative to an internal 
standard of 1,3,5-trimethoxybenzene. All data is shown as an average of three 
independent experiments to one standard deviation. **P<0.005  
Differences between 1-H and 1-Bn were also observed when 
analyzing the rate of product formation over time. Firstly, we found 
that both reactions were complete in <6 h. Reduction of 1-H was 
complete after 3 h, whereas the reduction of 1-Bn was rapid 
during the first 1.5 h (65% conversion) and then plateaued before 





reaching completion after 6 h (Figure 3B and Table S3). One 
explanation for this involves consideration of the effect(s) and 
relative location of 1-Bn/1-H in the cell interior. Hydrophobic 
compounds are known to partition in the membrane of E. coli 
(logPoctanol/water = 3.7 for 1-Bn vs –1.7 for 1-H at pH 7.4, Table S7) 
and this in-turn has been shown to accelerate glucose 
consumption via increased growth/maintenance demands.[7,8] 
Indeed, we found that a three-fold increase in cell density 
accelerated the reduction of 1-H after 1 h (72% yield at OD600=0.6 
vs. 92% yield at OD600=1.8, P<0.05) but decreased the 
conversion of 1-Bn (69% yield at OD600=0.6 vs. 36% yield at 
OD600=1.8, P<0.0005) (Figure 3C and Table S6). Furthermore, a 
prolonged elongation during cell division as a result of membrane 
stress can also increase the number of viable but non-culturable 
(VBNC) cells via rpoS-mediated pathways leading to higher cell 
density and reduced cell viability (Figure 3A and Table S9).[9] 
Together, these observations support the hypothesis that the 
decreased reduction of 1-Bn after 1.5 h results from the 
cumulative effects of an altered cell physiology leading to 
depleted glucose levels (Figure 3B).  
We next examined the effect of the reaction components on the 
reduction of 1-H. Product formation was reduced to <5% yield in 
the absence of cells or the presence of dead cells (heated to 95 
˚C for 15 min). No reduction was observed in blank media, spent 
supernatant or in media containing excess NADH (10 equiv., 24 
h). Conversely, 1-H was reduced in >98% yield using E. coli 
TOP10 or DH5 cells, and in 94% yield using BL21(DE3) cells 
containing no pEdinBrick plasmid (Figure 3D and Table S11). 
Together, this data supports the hypothesis that 1 is reduced in 
the cell by an enzyme that is native to E. coli. To explore this 
further we examined the reaction using the knock-out strains E. 
coli JW4114(K-12)∆frdB, JW1642(K-12)∆nemA, JW3052(K-
12)∆fadH and JW1692-2∆ppsA. FrdB encodes for the catalytic 
subunit of fumarate reductase, whereas nemA, fadH and ppsA 
encode for a N-ethylmaleimide reductase, 2,4-dienoyl-CoA 
reductase and phosphoenolpyruvate synthase, respectively. 
NemA, FadH and PpsA are homologs of the known KAC-
reductase YqjM from B. subtillus (Table S12). To our surprise, the 
reduction of 1-H was unaffected by the absence of the frdB, nemA 
or ppsA genes (77% ± 21%, 82% ± 4.6% and 91% ± 7.3% yield, 
respectively, P>0.05 relative to the parent Keio strain), whereas 
deletion of fadH reduced the product yield to 65% ± 6.0% (P<0.05, 
Figure 3D and Table S11). This partial yet significant effect has 
been observed whilst studying 
the reduction of nitroalkenes by 
E. coli BL21∆nemA.[3] Together, 
this suggests the presence of 
either a multifaceted KAC 
reduction pathway in the cell 
interior or a potentially novel 
C=C keto-acrylate reductase in 
the genome of Escherichia sp. 
 
Having shown that KAC 
reduction occurs rapidly under 
mild conditions using E. coli 
BL21(DE3) cells we next 
investigated the 
enantioselectivity of this 
process using ,-substituted 
substrates. We synthesized the 
- or -methyl substituted 
carboxylic acid and benzyl 
ester substrates 3-H-Me, 3-H-
Me, 3-Bn-Me and 3-Bn-Me 
from either glyoxal dimethyl 
acetal or pyruvic aldehyde 
dimethyl acetal in a similar 
manner to 1-Bn/H (see S2.1). 
Under our optimized conditions, 
the -methylated carboxylic 
acid 3-H-Me was reduced in 
79% and the corresponding 
benzyl ester 3-Bn-Me was 
reduced in 98% yield. 
Conversely, the -methylated 
isomers were both reduced in 
<5% yield (Figure 4A). Furthermore, both the - and -methyl 
benzyl ester substrates reduced cell viability by 1,500-fold, 
whereas the carboxylic acid congeners were biocompatible 
(Table S10). Analysis of the product of the reaction by chiral 
HPLC confirmed that the reduction of 3-Bn-Me was 
enantioselective, affording the reduced product in 87% e.r. The 
carboxylic acid 3-H-Me was reduced in 51% e.r. A cyclic -
substituted KAC substrate 6 was also reduced under the reaction 
conditions, affording the corresponding chiral cyclohexanone in 
44% yield and 62% e.r. Moving the benzyl group to the -position 
in 7 abolished any enantioselectivity. The simplified KAC 
substrate 5 was reduced in 100% yield and 77% e.r, whereas its 
Z-isomer was reduced in 69% yield and 79% e.r. In contrast, 
dimethyl maleate 8-Z was reduced in 78% yield, whereas 
dimethyl fumarate 8-E was reduced in 3% yield. Citraconate and 
itaconate di-esters (9 and Figure S3) and acrylate 10 were 
unreactive under the reaction conditions. 
Having confirmed the enantioselectivity of the reduction we 
moved on to apply the reaction to the synthesis of a target small 
molecule. Aminolevulinic acid (ALA, Levulan®, 13) is a naturally-
occurring non-proteogenic amino acid that is used as an additive 
in photodynamic therapy during the treatment of Paget’s disease 
and cancer.[10] Although access to ALA via engineered 
metabolism has been achieved, this has not translated into a 
viable industrial bio-process.[11] ALA is therefore currently 
produced on an industrial scale via the oxidation of 
petrochemically-derived furfurylamine followed by a Pd-catalyzed 
hydrogenation using H2(g). We reasoned that our E. coli-
Figure 3. Investigating the effect of the reaction on E. coli. A) The effect of increasing substrate concentration on culture 
density and product yield. B) Time-course analysis of product formation and glucose levels during the reaction. C) The 
effect of varying cell density on the initial rate of product formation using suspended whole-cells. D) Control experiments 
investigating the effect of the components of the reaction on the reduction of 1-H. Numbers indicated within the graphs 
represent the yield of the reaction. Substrates were added at 1 mM unless stated otherwise. All data is shown as an 
average of three independent experiments to one standard deviation. *P<0.05, ***P<0.0005, n/s = P>0.05 





mediated C=C reduction could achieve this same transformation 
without the need for toxic Pd salts or pressurized H2(g). To this 
end, we synthesized the butenolide hemiacetal 12 from lignin-
derived furan imide 11. Upon addition to E. coli BL21(DE3) cells, 
12 underwent ring-opening and C=C reduction, affording the 
reduced product in 81% isolated yield. Finally, the phthalimide 
was removed under acidic conditions to afford ALA in quantitative 
yield (Figure 4B). 
In general, the use of microbial cells is an operationally simple 
and green approach to fine chemical synthesis. In the case of this 
KAC reduction, E. coli BL21(DE3) cells are readily available, 
easily cultured, and possess all the cofactors and associated 
regeneration enzymes required to carry out C=C bond reduction. 
This avoids the use expensive exogenous reagents and 
circumvents the need for large-scale enzyme overexpression and 
purification, as purified enzymes must be continuously 
replenished via re-synthesis in the same way as a chemical 
reagent. The mild reaction conditions and absence of any 
transition metals also adds to the appeal of this process. This 
stands in stark contrast to modern abiotic methods for transition 
metal-free alkene reduction in synthetic organic chemistry, recent 
examples of which include: (i) transfer hydrogenation using 
diphenylamine, triethylsilane and the electrophilic cationic 
phosphonium catalyst [(C6F5)3PF)]+[B(C6F5)4]–, thiourea 
organocatalysis using a Hantzsch ester in refluxing H2O and (ii) 
the use of NaAlH4/C nanocomposites and 100 bar H2(g) in organic 
solvent at 150 ˚C for 48 h.[12] The biocompatibility of whole-cell 
reactions is also important, yet is rarely considered in the field of 
biocatalysis. Beyond substrate localization effects, biocompatible 
reactions can also be readily integrated into de novo metabolic 
pathways for renewable chemical production in microbial cells. 
 In summary, we have shown that unmodified laboratory 
strains of E. coli can be used for the reduction of keto-acrylic acids, 
esters and -substituted variants thereof. The reaction is efficient, 
occurs under mild conditions and uses no toxic transition metals 
or external reductants. The remarkable biocompatibility of this 
process led us to discover unique facets of the reaction in a 
cellular setting that will be used to inform the design of new whole-
cell reactions. This includes, to the best of our knowledge, the first 
observation that reactivity effects vary when substrates are 
localized to different regions of the cell. Finally, we applied this 
reaction to the synthesis of the valuable small molecule 
aminolevulinic acid, eliminating the requirement for the use of 
Pd/C and H2(g). Future studies will focus on identifying the 
enzyme(s) responsible for this reaction using comparative 
transcript-/proteomics and integration of this novel 
biotransformation into metabolic pathways for renewable small 
molecule synthesis via fermentation. 
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Alkene-Reducing Bugs: The microorganism Escherichia coli BL21(DE3) was found 
to reduce a range of keto-acrylic alkene substrates without the need for genetic 
modification. The reaction is mild, enantioselective and provides a green alternative 
to transition metal-based methods that utilize H2(g). The biocompatibility of the 
reaction was examined in a cellular setting and used to inform the metal-free 
synthesis of aminolevulinic acid from a lignin-derived substrate. 
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